Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 555 participants.
Also called NCT01169818
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 555 participants
- Sponsor
- Registry
-
NCT01169818
-
- Other papers using this trial's data
- Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational ATLAS study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China, India, Japan, Pakistan, Philippines, Russia
- Registry status
- Completed
Technical summary
Registry record NCT01169818. Randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2012-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus
- Acronym
- ATLAS
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Insulin Glargine
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01169818- Content hash
6d3f21de17747a628fa159db7053b616fb63c21f0377e169d6c50af31f1ce838